About this data
What it is
An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
Who files it
The investor, within days of crossing 5%, and again whenever the stake changes materially.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.

All of this comes from public filings.

Filings per day, last 30 days

0200400600800Oct 17 · 13D (activist): 0Oct 17 · 13G (passive): 0Oct 17Oct 18 · 13D (activist): 0Oct 18 · 13G (passive): 0Oct 19 · 13D (activist): 13Oct 19 · 13G (passive): 75Oct 20 · 13D (activist): 16Oct 20 · 13G (passive): 34Oct 21 · 13D (activist): 11Oct 21 · 13G (passive): 31Oct 21Oct 22 · 13D (activist): 16Oct 22 · 13G (passive): 48Oct 23 · 13D (activist): 13Oct 23 · 13G (passive): 24Oct 24 · 13D (activist): 0Oct 24 · 13G (passive): 0Oct 25 · 13D (activist): 0Oct 25 · 13G (passive): 0Oct 25Oct 26 · 13D (activist): 19Oct 26 · 13G (passive): 25Oct 27 · 13D (activist): 16Oct 27 · 13G (passive): 380Oct 28 · 13D (activist): 22Oct 28 · 13G (passive): 60Oct 29 · 13D (activist): 16Oct 29 · 13G (passive): 47Oct 29Oct 30 · 13D (activist): 16Oct 30 · 13G (passive): 343Oct 31 · 13D (activist): 0Oct 31 · 13G (passive): 0Nov 1 · 13D (activist): 0Nov 1 · 13G (passive): 0Nov 2 · 13D (activist): 20Nov 2 · 13G (passive): 36Nov 2Nov 3 · 13D (activist): 22Nov 3 · 13G (passive): 45Nov 4 · 13D (activist): 19Nov 4 · 13G (passive): 67Nov 5 · 13D (activist): 15Nov 5 · 13G (passive): 311Nov 6 · 13D (activist): 40Nov 6 · 13G (passive): 191Nov 6Nov 7 · 13D (activist): 0Nov 7 · 13G (passive): 0Nov 8 · 13D (activist): 0Nov 8 · 13G (passive): 0Nov 9 · 13D (activist): 40Nov 9 · 13G (passive): 140Nov 10 · 13D (activist): 27Nov 10 · 13G (passive): 289Nov 10Nov 11 · 13D (activist): 0Nov 11 · 13G (passive): 0Nov 12 · 13D (activist): 34Nov 12 · 13G (passive): 277Nov 13 · 13D (activist): 26Nov 13 · 13G (passive): 690Nov 14 · 13D (activist): 0Nov 14 · 13G (passive): 0Nov 14Nov 15 · 13D (activist): 0Nov 15 · 13G (passive): 0
0200400600800Oct 17 · 13D (activist): 0Oct 17 · 13G (passive): 0Oct 17Oct 18 · 13D (activist): 0Oct 18 · 13G (passive): 0Oct 19 · 13D (activist): 13Oct 19 · 13G (passive): 75Oct 20 · 13D (activist): 16Oct 20 · 13G (passive): 34Oct 21 · 13D (activist): 11Oct 21 · 13G (passive): 31Oct 21Oct 22 · 13D (activist): 16Oct 22 · 13G (passive): 48Oct 23 · 13D (activist): 13Oct 23 · 13G (passive): 24Oct 24 · 13D (activist): 0Oct 24 · 13G (passive): 0Oct 25 · 13D (activist): 0Oct 25 · 13G (passive): 0Oct 25Oct 26 · 13D (activist): 19Oct 26 · 13G (passive): 25Oct 27 · 13D (activist): 16Oct 27 · 13G (passive): 380Oct 28 · 13D (activist): 22Oct 28 · 13G (passive): 60Oct 29 · 13D (activist): 16Oct 29 · 13G (passive): 47Oct 29Oct 30 · 13D (activist): 16Oct 30 · 13G (passive): 343Oct 31 · 13D (activist): 0Oct 31 · 13G (passive): 0Nov 1 · 13D (activist): 0Nov 1 · 13G (passive): 0Nov 2 · 13D (activist): 20Nov 2 · 13G (passive): 36Nov 2Nov 3 · 13D (activist): 22Nov 3 · 13G (passive): 45Nov 4 · 13D (activist): 19Nov 4 · 13G (passive): 67Nov 5 · 13D (activist): 15Nov 5 · 13G (passive): 311Nov 6 · 13D (activist): 40Nov 6 · 13G (passive): 191Nov 6Nov 7 · 13D (activist): 0Nov 7 · 13G (passive): 0Nov 8 · 13D (activist): 0Nov 8 · 13G (passive): 0Nov 9 · 13D (activist): 40Nov 9 · 13G (passive): 140Nov 10 · 13D (activist): 27Nov 10 · 13G (passive): 289Nov 10Nov 11 · 13D (activist): 0Nov 11 · 13G (passive): 0Nov 12 · 13D (activist): 34Nov 12 · 13G (passive): 277Nov 13 · 13D (activist): 26Nov 13 · 13G (passive): 690Nov 14 · 13D (activist): 0Nov 14 · 13G (passive): 0Nov 14Nov 15 · 13D (activist): 0Nov 15 · 13G (passive): 0

13D (activist) 13G (passive)

Latest ownership filings

Reset

Showing: ticker ELVN

Latest ownership filings
FiledScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders.CompanyInvestorShares% of sharesFiling
Oct 27, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
BlackRock, Inc.5.21M7.1%SCHEDULE 13G/A ↗
Aug 6, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Abigail P. Johnson10.71M15.0%SCHEDULE 13G/A ↗
Aug 6, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
FMR LLC10.71M15.0%SCHEDULE 13G/A ↗
Jun 24, 2026SCHEDULE 13D/A (amended)ELVN
Enliven Therapeutics, Inc.
Orbimed Capital LLC00.0%SCHEDULE 13D/A ↗
Jun 24, 2026SCHEDULE 13D/A (amended)ELVN
Enliven Therapeutics, Inc.
Orbimed Genesis GP LLC219,4050.3%SCHEDULE 13D/A ↗
Jun 24, 2026SCHEDULE 13D/A (amended)ELVN
Enliven Therapeutics, Inc.
Orbimed Capital GP VII LLC6.56M9.2%SCHEDULE 13D/A ↗
Jun 24, 2026SCHEDULE 13D/A (amended)ELVN
Enliven Therapeutics, Inc.
Orbimed Advisors LLC6.77M9.5%SCHEDULE 13D/A ↗
Jun 22, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Polar Capital Funds PLC - Biotechnology Fund5.06M8.5%SCHEDULE 13G/A ↗
Jun 22, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Polar Capital LLP5.06M8.5%SCHEDULE 13G/A ↗
Jun 22, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Polar Capital Holdings Plc5.06M8.5%SCHEDULE 13G/A ↗
Jun 17, 2026SCHEDULE 13D/A (amended)ELVN
Enliven Therapeutics, Inc.
Orbimed Capital LLC31,1320.0%SCHEDULE 13D/A ↗
Jun 17, 2026SCHEDULE 13D/A (amended)ELVN
Enliven Therapeutics, Inc.
Orbimed Genesis GP LLC245,7280.3%SCHEDULE 13D/A ↗
Jun 17, 2026SCHEDULE 13D/A (amended)ELVN
Enliven Therapeutics, Inc.
Orbimed Capital GP VII LLC7.39M10.6%SCHEDULE 13D/A ↗
Jun 17, 2026SCHEDULE 13D/A (amended)ELVN
Enliven Therapeutics, Inc.
Orbimed Advisors LLC7.63M10.9%SCHEDULE 13D/A ↗
May 15, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Michael Kramarz4.80M7.7%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Robert Egen Atkinson4.80M7.7%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Commodore Capital Master LP4.80M7.7%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Commodore Capital LP4.80M7.7%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Bong Y. Koh1.73M2.8%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Nimish Shah1.73M2.8%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
VHCP Management EG, LLC1.73M2.8%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
VHCP Management III, LLC1.73M2.8%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Venrock Healthcare Capital Partners EG, L.P.1.73M2.8%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
VHCP Co-Investment Holdings III, LLC1.73M2.8%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Venrock Healthcare Capital Partners III, L.P.1.73M2.8%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Polar Capital Funds PLC - Biotechnology Fund5.06M8.5%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Polar Capital LLP5.06M8.5%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Polar Capital Holdings Plc5.06M8.5%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Polar Capital Funds PLC - Biotechnology Fund59.80M8.5%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Polar Capital LLP59.80M8.5%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Polar Capital Holdings Plc59.80M8.5%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Kiselak Tomas1.86M3.1%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Peter Harwin1.86M3.1%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Fairmount Healthcare Fund II L.P.1.86M3.1%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Fairmount Funds Management LLC1.86M3.1%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Ryan Wilder3.25M5.4%SCHEDULE 13G/A ↗
May 15, 2026SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Vestal Point Capital, LP3.25M5.4%SCHEDULE 13G/A ↗
Feb 17, 2026SCHEDULE 13GELVN
Enliven Therapeutics, Inc.
Ryan Wilder3.83M6.5%SCHEDULE 13G ↗
Feb 17, 2026SCHEDULE 13GELVN
Enliven Therapeutics, Inc.
Vestal Point Capital, LP3.83M6.5%SCHEDULE 13G ↗
Nov 14, 2025SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Bong Y. Koh3.23M5.4%SCHEDULE 13G/A ↗
Nov 14, 2025SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Nimish Shah3.23M5.4%SCHEDULE 13G/A ↗
Nov 14, 2025SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
VHCP Management EG, LLC3.23M5.4%SCHEDULE 13G/A ↗
Nov 14, 2025SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
VHCP Management III, LLC3.23M5.4%SCHEDULE 13G/A ↗
Nov 14, 2025SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Venrock Healthcare Capital Partners EG, L.P.3.23M5.4%SCHEDULE 13G/A ↗
Nov 14, 2025SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
VHCP Co-Investment Holdings III, LLC3.23M5.4%SCHEDULE 13G/A ↗
Nov 14, 2025SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Venrock Healthcare Capital Partners III, L.P.3.23M5.4%SCHEDULE 13G/A ↗
Nov 5, 2025SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Abigail P. Johnson7.87M13.3%SCHEDULE 13G/A ↗
Nov 5, 2025SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
FMR LLC7.87M13.3%SCHEDULE 13G/A ↗
Aug 14, 2025SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Michael Kramarz6.02M9.9%SCHEDULE 13G/A ↗
Aug 14, 2025SCHEDULE 13G/A (amended)ELVN
Enliven Therapeutics, Inc.
Robert Egen Atkinson6.02M9.9%SCHEDULE 13G/A ↗

The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 7:54 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances